ABCC7 p.Ser511Ala

CF databases: c.1532C>G , p.Ser511Cys (CFTR1) ? ,
Predicted by SNAP2: A: N (87%), C: N (72%), D: N (82%), E: N (93%), F: D (53%), G: N (87%), H: N (61%), I: N (78%), K: N (87%), L: N (78%), M: N (57%), N: N (93%), P: N (82%), Q: N (87%), R: N (82%), T: N (97%), V: N (82%), W: D (59%), Y: D (53%),
Predicted by PROVEAN: A: N, C: D, D: N, E: N, F: D, G: N, H: N, I: D, K: N, L: N, M: N, N: N, P: N, Q: N, R: N, T: N, V: N, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Treharne KJ, Crawford RM, Xu Z, Chen JH, Best OG, Schulte EA, Gruenert DC, Wilson SM, Sheppard DN, Kunzelmann K, Mehta A
Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the deltaF508 mutation: F508 deletion disrupts a kinase-binding site.
J Biol Chem. 2007 Apr 6;282(14):10804-13. Epub 2007 Feb 8., 2007-04-06 [PMID:17289674]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Treharne KJ, Xu Z, Chen JH, Best OG, Cassidy DM, Gruenert DC, Hegyi P, Gray MA, Sheppard DN, Kunzelmann K, Mehta A
Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR.
Cell Physiol Biochem. 2009;24(5-6):347-60. Epub 2009 Nov 4., [PMID:19910675]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Tosoni K, Stobbart M, Cassidy DM, Venerando A, Pagano MA, Luz S, Amaral MD, Kunzelmann K, Pinna LA, Farinha CM, Mehta A
CFTR mutations altering CFTR fragmentation.
Biochem J. 2013 Jan 1;449(1):295-305. doi: 10.1042/BJ20121240., [PMID:23067305]

Abstract [show]
Comments [show]
Sentences [show]